• Profile
Close

Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: A random open-label crossover study

International Journal of COPD Nov 09, 2017

Fujimoto K, et al. - The difference in efficacy of long-acting muscarinic antagonist (LAMA) and long-acting β2-agonists (LABAs) alone and the combination thereof for dynamic lung hyperinflation (DLH) were explained in this random open-label crossover study. Following metronome-paced incremental hyperventilation, the efficacy of tiotropium in inhibiting DLH could be superior to that of 150 μg indacaterol, even though the effects on airflow obstruction were the same. The combination therapy demonstrated further improvement in airflow obstruction, but not in DLH.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay